-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate, in Adults Aged 50 and ...
Allergens like mold, pollen, and dust, if you’re sensitive to them, can inflame the throat and affect mucus production. Post-nasal drip from the allergic reaction can cause you to constantly, and ...
For the adult indication, we look forward to moving VAX-31 into a Phase 3 program and plan ... Vaxcyte’s pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A ...
As spooky season approaches, the master of children’s horror recommends creepy-crawly classics and modern thrills for young readers. A graphic novel makes a powerful case that if these two men ...